Our client developed a novel product for the treatment of Serious Allergic Reactions (SAR) and wanted to obtain an intuitive and actionable segmentation of treaters in this space, in order to form a market understanding.
Research was therefore required to drive market shaping activities ahead of the launch of Product X.
We proposed a hybrid qual-quant approach to address all the client’s research objectives. Our research started with a definition phase, which was aimed at identifying available data sources, prior research, and collating themes/insights which was used to profile HCPs.
The last step of our research consisted of a segmentation workshop, which was aimed at exploring the initial customer segments, understand strategic implications (actionability) and create segment names which were meaningful to our client.
Final strategic recommendations were developed by considering all elements of the research. We provided our client with a report, helping them to understand:
Jump to a slide with the slide dots.
Ellie Forde and Zoe Callaghan, share experience of conducting research with patients with progressive or late-stage conditions and their caregivers.
Read moreFind out how we helped our client to identify segments among the patient population to enhance marketing efforts.
Read moreRapport is our monthly newsletter where we share our latest expertise and experience.